Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry

Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry

Background COVID‐19 is an infectious illness, featured by an increased risk of thromboembolism. However, no standard antithrombotic therapy is currently recommended for patients hospitalized with COVID‐19. The aim of this study was to evaluate safety and efficacy of additional therapy with aspirin o...

Full description

Bibliographic Details
Main Authors: Francesco Santoro, Ivan J. Núñez‐Gil, Enrica Vitale, María C. Viana‐Llamas, Rodolfo Romero, Charbel Maroun Eid, Gisela Feltes Guzman, Victor Manuel Becerra‐Muñoz, Inmaculada Fernández Rozas, Aitor Uribarri, Emilio Alfonso‐Rodriguez, Marcos García Aguado, Jia Huang, Alex Fernando Castro Mejía, Juan Fortunato Garcia Prieto, Javier Elola, Fabrizio Ugo, Enrico Cerrato, Jaime Signes‐Costa, Sergio Raposeiras Roubin, Jorge Luis Jativa Mendez, Carolina Espejo Paeres, Alvaro López Masjuan, Francisco Marin, Federico Guerra, Ibrahim El‐Battrawy, Bernardo Cortese, Harish Ramakrishna, Julian Perez‐Villacastín, Antonio Fernandez‐Ortiz, Natale Daniele Brunetti
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulation
antiplatelet therapy
aspirin
COVID‐19
prognosis
risk prediction
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.024530

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.024530

Similar Items